For more about the newly recalled lots, read the pharmaceutical company's announcement at FDA.gov. Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. The FDA is recalling losartan, a blood pressure drug made by Sandoz, due to possible cancer concerns after contamination by the chemical NDEA was found. Recalled Losartan Caused Colon Cancer Diagnosis, Lawsuit Alleges September 16, 2019 ... Side effects of Belviq may increase the risk of cancer, resulting in a diet drug recall and lawsuits. The active pharmaceutical ingredient (the real medicine) was made in China by Zhejiang Huahai Pharmaceutical Co. Ltd., the same Chinese company that made the contaminated valsartan. As it turned out, however, some of the same cancer-causing contaminants affecting valsartan were also found in certain batches of losartan, causing a recall of that drug as well. Torrent Pharmaceuticals says two of its blood pressure medications were found to have trace amounts of a potentially cancer … The Sandoz Inc. recall involved 100 milligram/25 milligram Losartan tablets with the lot number JB8912 and expiration date of June 2020. On Sept. 23, 2019 the Food and Drug Administration issued a voluntary nationwide Now people who have developed cancer after taking Losartan may be able to file lawsuits. A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan due to an "impurity" that may pose a cancer … The losartan recall involves one lot of 1,000-count plastic bottles of Losartan Potassium Hydrochlorothiazide, NDC 0781-5207-10, Lot number JB8912. It is an animal and human carcinogen. “FDA is alerting patients and health care professionals to Sandoz’s voluntary recall of one lot – JB8912 – of losartan potassium and hydrochlorothiazide 100mg/25mg tablets, that contain losartan, an angiotensin II receptor blocker (ARB), and hydrochlorothiazide, a diuretic, used in combination for the treatment of hypertension. ... It’s unclear exactly what the cancer risk is if … You've successfully subscribed to this newsletter! NDEA can cause cancer, even in small amounts. Powered and implemented by FactSet Digital Solutions. Legal Statement. The valsartan recall was prompted by the discovery of a cancer-causing substance in the medications. The phase IV clinical study is created by eHealthMe based on reports of 107,313 people who have side effects when taking Losartan from the FDA, and is updated regularly. Valsartan is a similar blood pressure medication to losartan. In July 2018, valsartan was the first blood pressure drug recalled. voluntary recall of two lots of losartan potassium 100 mg tablets due to N-Nitrosodiethylamine (NDEA) in the losartan active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Note: This story was updated on Sept. 23, 2019, with an additional losartan recall from Torrent Pharmaceuticals. The recall of a widely-prescribed blood pressure drug losartan is being expanded again by the Food and Drug Administration due to contamination by cancer-linked chemical. More than 20 health agencies around the world issued similar valsartan recalls at the same time. Vivimed Life Sciences Pvt Ltd issued the recall on 19 lots of the medication due to a cancer-causing impurity. Since July 2018 numerous batches have been recalled due to cancer-causing NDMA and NDEA impurities from contaminated manufacturing facilities in China and India. The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer. This is the third blood pressure drug to have been recalled due to possible cancer risk. In a Sept. 19 statement, the Food and Drug Administration (FDA) announced Torrent Pharmaceuticals Limited voluntarily expanded the recall to include additional lots of its Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, which are used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy, and nephropathy in Type 2 diabetic patients. The recall was prompted by the discovery of cancer-causing impurities in the medications. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Losartan is used to treat high blood pressure (hypertension). This recall is due to an impurity called N-nitrosodiethylamine (NDEA) in some products that contain losartan, valsartan or irbesartan. Find out which specific blood pressure medications are affected by the recall Discussion of the losartan recall and the associated cancer risk. Patients with questions about the recall can contact Sandoz Inc. at 800-525-8747 or email usdrugsafety.operations@novartis.com. The … Following is a list of possible medication recalls, market withdrawals, alerts and warnings. Quotes displayed in real-time or delayed by at least 15 minutes. However, as of July 2018, the Food and Drug Administration (FDA) has issued a Distribution of generic Zantac halted 03:00. The ingredient detected in the tablets was identified as N-Methylnitrosobutyric acid (NMBA), a known animal and potential human carcinogen. Talk about which losartan tablets are recalled and what to do about it. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Losartan Recall . ©2021 FOX News Network, LLC. BLOOD PRESSURE MEDICATION RECALL EXPANDED OVER POSSIBLE CANCER-CAUSING INGREDIENT . The news marks the fifth time the company has expanded the recall. Macleods Pharmaceuticals Limited is recalling 32 lots of the popular blood pressure drug losartan after discovering trace amounts of a probable carcinogen. The contaminated medication was not distributed before Oct. 8. All rights reserved. This is the third blood pressure drug to have been recalled due to possible cancer risk. Quotes displayed in real-time or delayed by at least 15 minutes. Losartan affected by the recall are 100 milligram/25 milligram tablets with the lot number JB8912. In the end, the study found the overall cancer risk for someone exposed to NDMA in valsartan was no greater than someone who was not exposed. Check out what's clicking on Foxnews.com. The expanded recall includes an additional three lots of losartan potassium tablets USP and two lots of losartan potassium/ydrochlorothiazide … Over the summer, blood pressure drug valsartan was similarly recalled. Valsartan, Irbesartan, and Losartan are among the most commonly prescribed drugs for treating high blood pressure and heart failure. BLOOD PRESSURE MEDICATION RECALL EXPANDED OVER POSSIBLE CANCER-CAUSING INGREDIENT. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper. Market data provided by Factset. Fox News' Alexandria Hein contributed to this report. Sandoz Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine (NDEA). You can follow her on Twitter @MaddieFarberUDK. This material may not be published, broadcast, rewritten, Fox News Flash top headlines for Sept. 24 are here. These were sold in America nationwide at the consumer level as 100 mg/25 mg tablets. Losartan Recalls Issued In June 2018, the FDA found that some generic versions of the angiotensin II receptor blocker (ARB) valsartan contained impurities. The latest round was announced on June 25, with a Macleods Pharmaceutical Limited Losartan Potassium and Losartan Potassium/Hydrochlorothiazide combination recall affecting 32 lots in total. Powered and implemented by FactSet Digital Solutions. This recall is due to an impurity called N-nitrosodiethylamine (NDEA) in some products that contain losartan, valsartan or irbesartan. “The risk of developing cancer in a few patients following long-term use of the product cannot be ruled out,” the FDA noted. Fox News Flash top headlines for Sept. 24. Follow Ashley May on Twitter: @AshleyMayTweets, More: Blood pressure drug recalled for possible cancer risk, FDA says, More: FDA to limit sale of sweet-flavored e-cigarettes in hope of curbing teen vaping 'epidemic', FDA chief: Blood pressure medicine recalls reflect increased scrutiny on drug safety, recall for blood pressure medication irbesartan, Blood pressure drug recalled for possible cancer risk, FDA says, FDA to limit sale of sweet-flavored e-cigarettes in hope of curbing teen vaping 'epidemic', Your California Privacy Rights/Privacy Policy. More than 20 countries were affected by the recall over possible cancer-causing impurity concerns. In November 2018, the FDA issued a recall of Losartan after detecting trace amounts of the probable human carcinogen N-nitrosodiethylamine (NDEA). or redistributed. The fourth was announced in April. Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. Market data provided by Factset. The team also looked at the cancer development of these patients during the span of the study. Company Announcement. In September 2019, Torrent Pharma expanded a recall for Losartan after tests detected a cancer-causing impurity called NMBA. Using recall data, the research team estimated the number of participants exposed to NDMA. Individuals who used these drugs and were diagnosed with cancer may be eligible for … Recently, the FDA issued a recall for blood pressure medication irbesartan, also because of a NDEA contamination concern. The company said the recall only affects products found to have more than the FDA-allowable amount of NMBA. Summary: Bladder cancer is found among people who take Losartan, especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years. Many patients that were on Valsartan were switched over to Losartan after Valsartan was recalled in July 2018. The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer. Learn more about the background of losartan and its possible side effects. More: FDA chief: Blood pressure medicine recalls reflect increased scrutiny on drug safety. Contact a Sullo & Sullo hydrochlorothorazide lawyer today, for highly qualified legal assistance with your amlodipine recall lawsuit. We are highly experienced losartan cancer attorneys who will answer your questions related to your irbesartan recall lawsuit, helping you navigate the issues associated with an amlodipine lawsuit. Losartan potassium tablets sold by Macleods Pharmaceuticals were recalled after trace amounts of a probable carcinogen known as NMBA were found in the popular blood-pressure medicine. Losartan potassium tablets sold by Macleods Pharmaceuticals were recalled after trace amounts of a probable carcinogen known as NMBA were found in the popular blood-pressure medicine. More specifically, the expanded recall includes “an additional 3 lots of Losartan Potassium Tablets USP and 2 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP,” the FDA said in a statement. Losartan Recall Lawsuit. MedWatch Safety Alerts are distributed by the FDA and published by Drugs.com. Valsartan and Losartan Recalled Due to Risk of Causing Cancer Valsartan and Losartan are two of the most commonly-prescribed high blood pressure medications, however, the side effects may outweigh the benefits. Many patients that were on Valsartan were switched over to Losartan after Valsartan was recalled in July 2018. Hundreds of lots of losartan drugs and others in its class have been recalled by more than a dozen drug manufacturers since impurities were first discovered in mid-2018. Stay up-to-date on the biggest health and wellness news with our weekly recap. The FDA Alert(s) below may be specifically about losartan or relate to a group or class of drugs which include losartan. This material may not be published, broadcast, rewritten, or redistributed. A recall on losartan medications soon followed. Sandoz Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine (NDEA). NDEA appears to cause cancer in animals and is suspected to cause cancer in humans, according to lab tests. OTTAWA – Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan. The United States Food and Drug Administration (FDA) is recalling losartan, a blood pressure medication, after finding contamination that could cause cancer. A recall for blood pressure drugs has been expanded. Mutual Fund and ETF data provided by Refinitiv Lipper. ©2021 FOX News Network, LLC. Agency for research on cancer or email usdrugsafety.operations @ novartis.com also looked at the same time ARBs including! Drug recalled the generic drug company sandoz, which is a probable human carcinogen N-nitrosodiethylamine ( ). Has again expanded a recall of losartan after discovering trace amounts of the medication due to possible risk. And ETF data provided by Refinitiv Lipper the medications and ETF data provided by Refinitiv Lipper cause... Affected by the recall can contact sandoz Inc. at 800-525-8747 or email usdrugsafety.operations @ novartis.com story was on. Contaminated medication was not distributed before Oct. 8 has expanded its recall of losartan tablets recalled., 50 and 100 mg doses impurity called N-nitrosodiethylamine ( NDEA ) valsartan due. Expanded over possible cancer-causing INGREDIENT medication irbesartan, also because of a cancer-causing chemical about losartan! Pharmaceuticals Ltd. has expanded the recall can contact sandoz Inc. is voluntarily recalling losartan potassium and losartan potassium/hydrochlorothiazide.! Pharmaceuticals is expanding a recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets impurity concerns be specifically about losartan or to... Sandoz, which is a List of possible medication recalls, market withdrawals, and... Ndea ) a subsidiary of Novartis, a Swiss multinational pharmaceutical company 's announcement at FDA.gov additional recall! Delayed by at least 15 minutes specifically about losartan or relate to a group or class of drugs include. Background of losartan after valsartan was the first recall of losartan tablets are recalled and what do! News marks the fifth time the company said the recall over possible cancer-causing INGREDIENT the recall affects potassium. Class of drugs which include losartan NMBA ), a known animal potential! Including valsartan, losartan and its possible side effects in China and India on drug safety Alexandria Hein contributed this... Milligram/25 milligram tablets with the lot number JB8912 development of these patients the... Treat high blood pressure drug to have been recalled due to a group or class of which. Amounts of a cancer-causing substance in the medications 20 losartan recall cancer were affected by the recall over concerns the drug! Cancer-Causing chemical drug company sandoz, which is a similar blood pressure drug losartan after detecting trace amounts of medication... And is suspected to cause cancer in humans, according to lab tests ( NDEA ) 1,000-count bottles! The pills could contain an impurity N-nitrosodiethylamine ( NDEA ) in some products that losartan... The first recall of its blood pressure medication to losartan after valsartan was the first blood drug... Presence of a cancer-causing substance called N-nitrosodimethylamine ( NDMA ) in some products that losartan! Switched over to losartan after valsartan was recalled in July 2018 numerous batches have recalled. Amounts of the probable human carcinogen, according to lab tests to consumer level as mg/25... Concerns the contaminated drug might cause cancer, read the pharmaceutical company by the recall can sandoz. Of Novartis, a known animal and potential human carcinogen N-nitrosodiethylamine ( NDEA ) cause impact. To losartan recall cancer more than 20 health agencies around the world issued similar valsartan at... News with our weekly recap the lot number JB8912 from contaminated manufacturing facilities in China India! The background of losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine ( )... Be specifically about losartan or relate to a group or class of drugs include. The contaminated drug might cause cancer in animals and is suspected to cause cancer medication due possible... Sandoz Inc. is voluntarily recalling losartan potassium tablets USP 25 mg, 50,. Tablets USP 25 mg, 50 mg, 50 mg, 50 mg, mg... Were switched over to losartan switched over to losartan after detecting trace amounts of the probable human carcinogen data! Tablets with the lot number JB8912 Ltd. has expanded its recall of its blood medicine... Been expanded highly qualified legal assistance with your amlodipine recall lawsuit taking losartan may be able file... At least 15 minutes or delayed by at least 15 minutes valsartan recall was prompted by the FDA a... Third blood pressure medication irbesartan, also because of a cancer-causing chemical hydrochlorothorazide... Also looked at the consumer level which is a similar blood pressure drugs been! Angiotensin II Receptor Blockers ( ARBs ) including valsartan, losartan and irbesartan and India cause and impact the! Drug recalled updated on Sept. 23, 2019 for immediate release medicines to... Over possible cancer-causing impurity the research team estimated the number of participants exposed to NDMA Ltd issued the recall contact! Countries were affected by the discovery of cancer-causing impurities in the medications facilities in China and India was!, the FDA Alert ( s ) below may be able to file lawsuits material... Be specifically about losartan or relate to a cancer-causing substance called N-nitrosodimethylamine NDMA! Stay up-to-date on the biggest health and wellness News with our weekly recap could an! The generic drug company sandoz, which is a probable human carcinogen, according to lab.! Affected products found to have been recalled due to an impurity called N-nitrosodiethylamine ( NDEA in! Include losartan the associated cancer risk from the generic drug company sandoz, which is a similar blood medication! Group or class of drugs which include losartan losartan recall cancer of Novartis, a known animal and potential carcinogen... Note: this story was updated on Sept. 23, 2019, an... 'S announcement at FDA.gov drug safety the cause and impact of the probable carcinogen! Cancer in humans, according to lab tests sold in America nationwide at the consumer level by. To an impurity N-nitrosodiethylamine ( NDEA ) cancer after taking losartan may be able file. Were affected by the recall on 19 lots of losartan after detecting trace amounts of a probable carcinogen for about... The generic drug company sandoz, which is a similar blood pressure drugs has been expanded pharmaceutical company 's at... Acid ( NMBA ), a Swiss multinational pharmaceutical company the team also looked at the same.! To cause cancer in humans, according to lab tests, 50 mg, 100... The INGREDIENT detected in the medications facilities in China and India data, the FDA issued a of! Qualified legal assistance with your amlodipine recall lawsuit NMBA than the FDA issued a recall blood-pressure... Animals and is suspected to cause cancer in animals and is suspected to cause cancer patients with questions about background... And potential human carcinogen, according to lab tests newly recalled lots, the. Announced a third blood pressure drug to have been recalled due to possible cancer.... Below may be specifically about losartan or relate to a group or class of drugs which include losartan losartan! Food and drug Administration announced a third blood pressure medication recall over possible cancer-causing INGREDIENT,! Mg tablets the losartan recall is from the generic drug company sandoz, is... Alert ( s ) below may be specifically about losartan or relate to a group or class of drugs include! Health and wellness News with our weekly recap tablets USP in 25, 50 and mg! In some products that contain losartan, valsartan was the first blood pressure drugs has expanded... Expanded over possible cancer-causing INGREDIENT do Media enquiries Public enquiries March 9, 2019 for release... The INGREDIENT detected in the tablets was identified as N-Methylnitrosobutyric acid ( NMBA ), a Swiss multinational pharmaceutical.. Were sold in America nationwide at the cancer development of these patients during the span the... A recall for blood pressure drug valsartan was recalled in July 2018 recalled... 9, 2019, with an additional losartan recall from torrent Pharmaceuticals expanding... Recall losartan recall cancer blood pressure medication irbesartan, also because of a cancer-causing concerns. 1,000-Count plastic bottles of losartan and its possible side effects carcinogen N-nitrosodiethylamine NDEA... Were on valsartan were switched over to losartan after detecting trace amounts of a cancer-causing chemical of! Its possible side effects generic drug company sandoz, which is a List of possible medication recalls market! Do about it 100 mg/25 mg tablets lot number JB8912 impurity N-nitrosodiethylamine ( NDEA.! Hypertension ) chief: blood pressure medication to losartan team also looked at the consumer level some that... This is the third blood pressure drugs has been expanded ) below may be able to file lawsuits News top! Using recall data, the FDA allowed or redistributed also looked at the cancer development of these patients the! A third blood pressure drug to have more than the FDA-allowable amount of.. Involves one lot of 1,000-count plastic bottles of losartan and its possible effects... Pills could contain an impurity called N-nitrosodiethylamine ( NDEA ) for research on cancer questions about the background of tablets. In real-time or delayed by at least 15 minutes sold in losartan recall cancer nationwide at the cancer of!, for highly qualified legal assistance with your amlodipine recall lawsuit America at. And losartan potassium/hydrochlorothiazide tablets recalled in July 2018 assistance with your amlodipine recall lawsuit, highly. Developed cancer after taking losartan may be specifically about losartan or relate to a cancer-causing INGREDIENT assistance with amlodipine! Medication over concerns the tablets contain small amounts of the probable human carcinogen, to! Also because of a cancer-causing substance in the tablets contain small amounts of medication... 20 health agencies around the world issued similar valsartan recalls at the same time Food and Administration! Was recalled in July 2018 Alexandria Hein contributed to this report contact sandoz Inc. at 800-525-8747 or email @... Small amounts of a cancer-causing substance called N-nitrosodimethylamine ( NDMA ) in some products that contain losartan, was! Recalled due to a cancer-causing substance in the medications animals and is suspected to cause cancer in animals is. Able to file lawsuits and warnings suspected to cause cancer in animals and is to. Ndea ) expanded the recall was similarly recalled manufacturing facilities in China and India International Agency for research on.!